Austin-based Cassava Sciences has reached a settlement agreement in a years-long investor lawsuit that centered on allegations about how the company presented clinical trial results for its Alzheimer’s drug candidate.
Read More from Bizjournals.com Feed (2025-02-17 17:47:29)
